Sourced from:Manufacturer Authorized Distributor
Quick Summary
Vildanat M 50mg/500mg Tablet
Last updated on 26 Sep 2026 | 08:43 AM (IST)
₹59
MRP: ₹63.75
(You Save ₹4.75)
10 TABLET(s) IN A STRIP
Sourced from:Manufacturer Authorized Distributor
Vildanat M 50mg/500mg Tablet
Salt Composition
METFORMIN,VILDAGLIPTINMarketer
NATCO PHARMA LTD
7% OFF
₹59
MRP: ₹63.75
Inclusive of all taxes
7% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Better Service Satisfied Customers
Introduction to Vildanat M 50mg/500mg Tablet
Vildanat M 50mg/500mg Tablet is an antidiabetic drug that belongs to a class of drugs called dipeptidyl peptidase-4 inhibitors containing the active ingredient Vildagliptin. This medication is indicated in patients with type 2 diabetes mellitus. Type 2 diabetes is a condition in which the blood sugar (glucose) level is high in the body. It occurs when the body cells become resistant to the effect of insulin. As a result of this insulin resistance, the blood glucose level in the body increases. In type 2 diabetes, the body does not make sufficient insulin, or the insulin that is produced is not used well. It is otherwise also known as non-insulin-dependent diabetes mellitus, and since it usually occurs past middle age, it is also widely referred to as mature onset diabetes.
If you suspect an allergy to the drug or its components, avoid taking the medicine and consult your doctor. This drug is not recommended in individuals with diabetic ketoacidosis, a serious complication of diabetes caused by high blood sugar and the presence of ketones in the blood. If you are taking an anti-diabetic medicine known as sulphonylurea if you are on dialysis due to kidney problems or liver disease, or if you have had heart failure or a history of pancreatic disease. Your doctor may need to adjust the drug dose when taking it together with Vildanat M 50mg/500mg Tablet to prevent low blood glucose (hypoglycemia).
This drug should not be used during pregnancy unless specifically advised by your physician. Notify your physician if you are pregnant, suspecting, or planning for the pregnancy. It is not known whether Vildanat M 50mg/500mg Tablet passes into breast milk. You should not use this drug if you are breastfeeding or plan to breastfeed. This medication is not to be taken by children and adolescents under 18. This recommendation is likely due to this age group's limited safety and efficacy data.
Uses of Vildanat M 50mg/500mg Tablet
- Treatment of Type 2 Diabetes mellitus
Therapeutic Effects of Vildanat M 50mg/500mg Tablet
Vildanat M 50mg/500mg Tablet works by inhibiting the enzyme DPP-4. This enzyme breaks down incretin hormones, which are responsible for increasing insulin release and decreasing glucagon secretion. By inhibiting DPP-4, this drug prolongs the action of incretin hormones, leading to better blood sugar control.
Interaction of Vildanat M 50mg/500mg Tablet with other drugs
Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications, such as thiazides and corticosteroids, may interact with Vildanat M 50mg/500mg Tablet and reduce effectiveness by causing undesirable side effects.
More Information about Vildanat M 50mg/500mg Tablet
- Store Vildanat M 50mg/500mg Tablet at a temperature below 25˚C.
- Protect from light and moisture.
How to consume Vildanat M 50mg/500mg Tablet
Take the Vildanat M 50mg/500mg Tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advice for Vildanat M 50mg/500mg Tablet
Breast Feeding
It is not known whether Vildanat M 50mg/500mg Tablet passes into breast milk. If you are breastfeeding or plan to breastfeed, you should not use this drug.
Alcohol
It is unknown whether consuming alcohol while taking Vildanat M 50mg/500mg Tablet is safe or not. So, consult your doctor for more information.
Liver
Vildanat M 50mg/500mg Tablet should be cautiously administered in patients with severe liver diseases. Inform your physician if you have liver problems before initiating the therapy.
Lungs
It is unknown whether Vildanat M 50mg/500mg Tablet is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
Driving
If you experience dizziness while taking Vildanat M 50mg/500mg Tablet, it is important not to drive or operate machinery. Dizziness can impair your ability to perform tasks that require focus and coordination.
Pregnancy
Vildanat M 50mg/500mg Tablet should not be used during pregnancy unless specifically advised by your physician. If you are planning to become pregnant or think you may be pregnant, it is essential to consult your doctor before taking this medicine.
Side Effects of Vildanat M 50mg/500mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Angioedema
- Liver disease (hepatitis)
- Inflammation of the pancreas (pancreatitis)
Common
- Itchy rash
- Trembling
- Headache
- Dizziness
- Muscle pain
- Joint pain
- Constipation
- Excessive sweating
- Vomiting
- Diarrhoea
- Heartburn
- Nausea (feeling sick)
- Blurred vision.
Word of Advice
Vildanat M 50mg/500mg Tablet is most effective when combined with a healthy diet and regular exercise. Work closely with your physician and a registered dietitian to develop a diabetes management plan that includes lifestyle modifications. Regularly monitor your blood sugar levels as advised by your doctor. This will help you and your physician assess the effectiveness of the medication and make any necessary adjustments.
FAQs about Vildanat M 50mg/500mg Tablet
Q1.
Is Vildanat M 50mg/500mg Tablet a substitute for insulin?
Vildanat M 50mg/500mg Tablet is not a substitute for insulin. It is used to help manage blood sugar levels in type 2 diabetes, but it does not replace insulin therapy. In some cases, Vildanat M 50mg/500mg Tablet may be used alongside insulin treatment.
Q2.
Can Vildanat M 50mg/500mg Tablet be taken with other diabetes medications?
Vildanat M 50mg/500mg Tablet is often used in combination with other diabetes medications, such as metformin or sulfonylureas, to achieve better blood sugar control. Your physician will determine the most suitable treatment plan for you.
Q3.
Is Vildanat M 50mg/500mg Tablet a cure for diabetes?
Vildanat M 50mg/500mg Tablet is not a cure for diabetes. It is a medication that helps manage blood sugar levels, but it does not eliminate the underlying causes of type 2 diabetes. Lifestyle modifications, such as diet and exercise, are also important for diabetes management.
Q4.
Can Vildanat M 50mg/500mg Tablet be used in children with diabetes?
Vildanat M 50mg/500mg Tablet is typically not approved for use in children with diabetes. Its safety and effectiveness in pediatric patients may not be established.
Q5.
How should I take Vildanat M 50mg/500mg Tablet?
You should take Vildanat M 50mg/500mg Tablet exactly as prescribed by your physician. Typically, it is taken orally, with or without food, usually once or twice a day. Follow your doctor's instructions carefully.
Fact Box of Vildanat M 50mg/500mg Tablet
Molecule name: Vildagliptin | Therapeutic class: Antidiabetic agent |
Pharmacological class: Dipeptidyl peptidase-4 (DPP4) inhibitors | Indications: Treatment of Type 2 Diabetes mellitus |
References
- Pharmadox Healthcare Ltd., Electronic Medicines Compendium (EMC), [Revised on August 2023] [Accessed on 14th Sept 2023], https://www.medicines.org.uk/emc/files/pil.14380.pdf
- Galenicum Health, S.L, [Revised on April 2023] [Accessed on 14th Sept 2023], https://medicinesauthority.gov.mt/file.ashx?f=0594EAF2C2622B403776FD1C302BFCBAFBF6CB6184EDD15C
- Martha S. Nolte Kennedy, Umesh Masharani, Pancreatic Hormones & Anti-diabetic Drugs, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 747-771.
- KD Tripathi, Insulin, Oral Antidiabetic Drugs and Glucagon, Essentials of Medical Pharmacology, 8th Edition, 2019, 280-305.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. B. Deiva
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:43 AM (IST)
Want to know more?
Read Our Editorial Policy